September 02, 2014
A Delaware federal judge on Friday found Novartis Pharmaceuticals Corp. hadn't shown Par Pharmaceutical Inc. infringed a patent for a patch that treats Alzheimer's disease, asking the generic-name drugmaker to file a draft of a final judgment in its favor in the consolidated suit.
June 18, 2014
A Delaware federal judge on Wednesday found that Watson Laboratories Inc. infringed on two of Novartis Pharmaceuticals Corp.'s patents for a patch that treats Alzheimer's disease, asking the brand-name drugmaker to file a draft of a final judgment in its favor.
November 04, 2011
Pharmaceutical giant Novartis Pharmaceuticals Corp. lodged a patent infringement suit in Delaware on Thursday, seeking to stop Actavis Inc. from marketing a generic form of Novartis' Exelon patch used to treat dementia patients.